Sanofi has filed two separate federal lawsuits against Moderna and Pfizer, alleging that several major Covid-19 and RSV vaccines infringe its mRNA delivery patents. The French pharmaceutical giant, listed on US markets
More
Cryoport Systems is repositioning the conversation around supply chains for advanced therapies, arguing that quality must be embedded from the ground up rather than applied as an afterthought. Adam Fox, Chief Quality
More
Merck (MRK) has announced that its flagship cancer drug Keytruda has achieved a landmark result in the treatment of a specific endometrial cancer subtype. The drug became the first PD-1 inhibitor to
More
Pharma’s third-party logistics sector is undergoing a fundamental transformation, moving well beyond its traditional role of shifting pallets through wholesale distribution chains. The industry is now contending with smaller patient populations, highly
More
Celcuity has secured FDA approval for gedatolisib, now branded as Revtorpyk, marking a significant milestone in the treatment of hormone receptor-positive, HER2-negative breast cancer. The regulator approved Revtorpyk specifically for previously treated
More
The Trump administration’s April 2026 announcement of a 100% base levy on imported APIs and patented drugs has forced a sweeping re-evaluation of pharmaceutical supply chains across the industry. Reshoring pharmaceutical manufacturing
More
AstraZeneca (AZN) has signed a global exclusive licence agreement with Dizal to acquire worldwide rights to develop and commercialise Zegfrovy, also known as sunvozertinib. The deal comprises a $600 million upfront payment
More
The pharmaceutical distribution sector is undergoing a significant transformation, driven by the need to balance highly targeted delivery models with large-scale operational demands. Modern drug supply chains are increasingly complex, requiring distributors
More
GSK is preparing to seek FDA accelerated approval for its cancer drug Jemperli after a phase 2 trial delivered a significant clinical win in a high-profile cancer indication. Interim results from the
More
Insulet Corporation (NASDAQ: PODD), maker of the Omnipod tubeless insulin pump, has announced a global partnership with mental health app Calm to support the emotional wellbeing of people living with diabetes. The
More